Overview

Perioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac surgERies - the PATHFINDER II Study

Status:
Not yet recruiting

Trial end date:
2023-09-01

Target enrollment:

Participant gender:

Summary

In the PATHFINDER 2 trial, we will test our intraoperative EEG-guided multimodal general anesthesia (MMGA) management strategy in combination with a postoperative protocolized analgesic approach to: 1. ensure hemodynamic stability and decrease use of vasopressors in the operating rooms 2. reduce pain and opioid consumption postoperatively 3. reduce the incidence of perioperative neurocognitive dysfunction in cardiac surgical patients

Phase:

N/A

Details

Lead Sponsor:

Beth Israel Deaconess Medical Center

Treatments:

Dexmedetomidine
Ketamine
Propofol
Remifentanil
Rocuronium
Ropivacaine